Rafferty Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.49M | Sell |
143,852
-36,282
| -20% | -$628K | 0.01% | 552 |
|
2025
Q1 | $3.94M | Sell |
180,134
-61,340
| -25% | -$1.34M | 0.02% | 420 |
|
2024
Q4 | $7.71M | Buy |
241,474
+37,328
| +18% | +$1.19M | 0.03% | 328 |
|
2024
Q3 | $5.89M | Sell |
204,146
-37,836
| -16% | -$1.09M | 0.02% | 388 |
|
2024
Q2 | $9.28M | Buy |
241,982
+93,181
| +63% | +$3.57M | 0.03% | 295 |
|
2024
Q1 | $8.75M | Buy |
148,801
+5,683
| +4% | +$334K | 0.03% | 318 |
|
2023
Q4 | $8.57M | Sell |
143,118
-71,043
| -33% | -$4.25M | 0.04% | 321 |
|
2023
Q3 | $8.15M | Buy |
214,161
+121,893
| +132% | +$4.64M | 0.05% | 281 |
|
2023
Q2 | $8.41M | Sell |
92,268
-17,130
| -16% | -$1.56M | 0.05% | 250 |
|
2023
Q1 | $7.22M | Sell |
109,398
-54,706
| -33% | -$3.61M | 0.05% | 282 |
|
2022
Q4 | $8.49M | Buy |
164,104
+61,532
| +60% | +$3.18M | 0.07% | 236 |
|
2022
Q3 | $7.01M | Buy |
102,572
+9,683
| +10% | +$661K | 0.07% | 220 |
|
2022
Q2 | $4.2M | Sell |
92,889
-30,606
| -25% | -$1.38M | 0.04% | 311 |
|
2022
Q1 | $6.28M | Sell |
123,495
-2,415
| -2% | -$123K | 0.04% | 315 |
|
2021
Q4 | $5.95M | Buy |
125,910
+36,711
| +41% | +$1.74M | 0.03% | 307 |
|
2021
Q3 | $2.94M | Buy |
89,199
+47,208
| +112% | +$1.56M | 0.02% | 488 |
|
2021
Q2 | $2.65M | Sell |
41,991
-29,421
| -41% | -$1.86M | 0.02% | 554 |
|
2021
Q1 | $3.06M | Buy |
71,412
+52,653
| +281% | +$2.26M | 0.02% | 478 |
|
2020
Q4 | $1.07M | Sell |
18,759
-50,470
| -73% | -$2.89M | 0.01% | 482 |
|
2020
Q3 | $2.09M | Buy |
69,229
+38,410
| +125% | +$1.16M | 0.03% | 401 |
|
2020
Q2 | $1.01M | Buy |
30,819
+22,557
| +273% | +$737K | 0.01% | 540 |
|
2020
Q1 | $221K | Sell |
8,262
-61,996
| -88% | -$1.66M | 0.01% | 501 |
|
2019
Q4 | $2.15M | Buy |
70,258
+10,579
| +18% | +$324K | 0.03% | 363 |
|
2019
Q3 | $1.44M | Sell |
59,679
-5,124
| -8% | -$123K | 0.02% | 465 |
|
2019
Q2 | $1.64M | Buy |
64,803
+37,450
| +137% | +$949K | 0.03% | 463 |
|
2019
Q1 | $533K | Buy |
+27,353
| New | +$533K | 0.01% | 656 |
|